A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found.
The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS.
The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared to the current drug interferon beta-1a which is known commercially as Rebif.
More top news
Hiker who walked from Mexico to Canada took a selfie on every single mile - charting the transformation of himself and the terrain.
Research into property prices has found London has more areas with an average price of more than £1m than anywhere else in the UK.
It's been a messy day for many with a mixture of heavy showers, thunder and blustery winds affecting parts of the UK.